Ariel Hurley - 16 Nov 2021 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Signature
/s/ Tracey McCain, Attorney-in-Fact
Issuer symbol
BPMC
Transactions as of
16 Nov 2021
Net transactions value
-$206,811
Form type
4
Filing time
18 Nov 2021, 15:06:15 UTC
Previous filing
27 Sep 2021
Next filing
03 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $1,309 +700 +6.9% $1.87* 10,797 16 Nov 2021 Direct F1
transaction BPMC Common Stock Options Exercise $5,720 +650 +6% $8.80* 11,447 16 Nov 2021 Direct F1
transaction BPMC Common Stock Options Exercise $9,006 +600 +5.2% $15.01 12,047 16 Nov 2021 Direct F1
transaction BPMC Common Stock Sale $222,846 -1,950 -16% $114.28 10,097 16 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -700 -16% $0.000000 3,654 16 Nov 2021 Common Stock 700 $1.87 Direct F1, F2
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -650 -48% $0.000000 714 16 Nov 2021 Common Stock 650 $8.80 Direct F1, F3
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -600 -16% $0.000000 3,200 16 Nov 2021 Common Stock 600 $15.01 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effected pursuant to a trading plan adopted on March 12, 2021 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 This option was granted on October 8, 2014 and is fully vested as of the date hereof.
F3 This option was granted on February 10, 2015 and is fully vested as of the date hereof.
F4 This option was granted on February 3, 2016 and is fully vested as of the date hereof.